Biocodex Announces DIACOMIT® Oral Suspension for Dravet Syndrome
14 Nov 2024 //
PR NEWSWIRE
Biocodex Invites Canadian Academics To Apply For Research Grant
30 Sep 2024 //
GLOBENEWSWIRE
Biocodex Invites Canadians For ‚25K Microbiota Research Grant
30 Apr 2024 //
GLOBENEWSWIRE
The Biocodex Group Strengthens Its Position in Microbiota
17 Jan 2024 //
BUSINESSWIRE
The Biocodex Microbiota Foundation calls for Canadian proposals to study the microbiome`s role
31 Jul 2023 //
GLOBENEWSWIRE
Biocodex Strengthens Its Position in US Market With the Acquisition of Hilma
17 Nov 2022 //
BUSINESSWIRE
Antiseizure Drug DIACOMIT Now Approved for Children as Young as 6 Months
21 Sep 2022 //
PRNEWSWIRE
PANTHERx Rare Announces Partnership with Biocodex for Distribution of DIACOMIT
27 Jun 2022 //
PRNEWSWIRE
M8 Pharmaceuticals Bags License of Exclusive rights for Diacomit from Biocodex
14 Sep 2021 //
PRNEWSWIRE
Encoded Therapeutics bags $104M to propel `precision gene therapy’
26 Jun 2019 //
FIERCE BIOTECH
Neurim Pharmaceuticals Paediatric Prolonged-Release Melatonin
13 Mar 2017 //
PR NEWSWIRE
Global Insomnia Market - Market Research Analysis 2015-2019
05 Nov 2015 //
PR NEWSWIRE
DRL surges; company announces strategic alliance with Biocodex
03 Nov 2015 //
THE ECONOMIC TIMES